US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Neurizon Therapeutics Ltd (PAAOA) 銘柄情報

Neurizon Therapeutics Ltd (PAAOA)

0.11

0.00

(0.00%)

終了 6月9日 3:00PM

Neurizon Therapeutics Ltd (PAAOA) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.11

( - )

買値

0.11

売値

0.12

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.11

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 584,125

発行済株式数

746,274,115

配当利回り

PER

-2.03

1 株当たり利益 (EPS)

-0.03

歳入

5.98M

純利益

-14.85M

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.neurizon.com

本社

Melbourne, Australia

設立

2026

Neurizon Therapeutics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker PAAOA. The last closing price for Neurizon Therapeutics was AUD0.11. Over the last year, Neurizon Therapeutics shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Neurizon Therapeutics currently has 746,274,115 shares in issue. The market capitalisation of Neurizon Therapeutics is AUD82.09 million. Neurizon Therapeutics has a price to earnings ratio (PE ratio) of -2.03.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PAAOA - Frequently Asked Questions (FAQ)

What is the current Neurizon Therapeutics Ltd share price?

The current share price of Neurizon Therapeutics Ltd is AUD 0.11

How many Neurizon Therapeutics Ltd shares are in issue?

Neurizon Therapeutics Ltd has 746,274,115 shares in issue

What is the market cap of Neurizon Therapeutics Ltd?

The market capitalisation of Neurizon Therapeutics Ltd is AUD 82.09M

What is the 1 year trading range for Neurizon Therapeutics Ltd share price?

Neurizon Therapeutics Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Neurizon Therapeutics Ltd?

The price to earnings ratio of Neurizon Therapeutics Ltd is -2.03

What is the cash to sales ratio of Neurizon Therapeutics Ltd?

The cash to sales ratio of Neurizon Therapeutics Ltd is 7.49

What is the registered address of Neurizon Therapeutics Ltd?

The registered address for Neurizon Therapeutics Ltd is Suite 2, Melbourne, Victoria, 3000

What is the Neurizon Therapeutics Ltd website address?

The website address for Neurizon Therapeutics Ltd is www.neurizon.com

TightCoil

TightCoil 5分前

They stayed off their lows
like the plague...good sign
for tomorrow

packerfan9

packerfan9 5分前

What does that mean in revenues. Again never tell us in PR;s. Never file financials. Why. Do not sell much, losses and billions more in dilution. If results were good they file. Wake up it is scam.

Poo28

Shareholders must ignore ANY attempt at a Company valuation, without credentials and without standing according to the SEC. No bonified expert in 21st century trading uses a manufacturing fundamental methodology which has no basis in technology or B2B business .

There are SEC Fin

ollik78

ollik78 6分前

And there it goes again … SUNE 💵💵💵

88TH MAN

88TH MAN 6分前

Xeriant (XERI), what a winner!

BBANBOB

BBANBOB 6分前

I guess because they want to preserve an honest reporting reputation.
You know the good and the bad about housing

ollik78

ollik78 7分前

CCTG next 2000% 🤣🤣🚬🧨

Horsts

Can’t be regular.Congratulations to all the happy ones who made a lot Bucks here.But apart from that, it can’t be serious/honest/legal or anything like that.But much fun with spreading the money after selling this

rosemountbomber

rosemountbomber 8分前

Totally agree that if there are any inroads into the Fibrate market, the Generics will take the majority of it. I say if because the FDA has been knocking fibrates for years and there are still a ton of scripts written for them. State of knowledge or education within the medical community.

Ooou812

Ooou812 8分前

Just oversold my opinion.

MC10459

MC10459 8分前

Fluidity is also important with dividend-paying companies. Where do you get your information from?

BardConqueror231

BardConqueror231 8分前

https://www.linkedin.com/posts/hydrograph-graphene-coatings-ugcPost-7469733500573597696-5x9L/?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAADgDxYBW7iA8VvNKRAmp-oKwii2CFdnug0

ssc

Have at it Jetmek if you're having fun. But as you have probably already figured out, you are debating with a proven liar with thousands of documented baseless claims, false rumors and outright lies while attempting to promote this same naked short seller nonsense (quite unsuccessfully I might add)

BBANBOB

BBANBOB 9分前

split it aint pretty as it got real ugerly late in the day as it was neck and neck buy versus sell all day

Buy: 3,724,182 Neutral: 7,374,990 Sell: 10,181,529

pumper_stumper

pumper_stumper 9分前

It's fun watching this POS fall 97% since Jan 1, and still see people without a clue holding! Amazing, but fun! And no, saying "copper" is not due diligence! See you at 0.0001!

ToucanYoucan

ToucanYoucan 9分前

$TWOH - Do I really need to point out to you that your stock sells for $.0001 per share?. It should have 150 million in volume every day.

glenn1919

glenn1919 9分前

STAK......................a/h

Shrinky Dynk

Shrinky Dynk 10分前

They announce anything Big like they are saying and this will definitely take off..... $PSRU

fliper

fliper 10分前

mat23

Nice too see some volume today, as well as some recent news & earnings.

HoldHigh

HoldHigh 11分前

Don't think we're anywhere near the chart reading base of 6.50. Back up the truck we need to load up the cash. 💰️

In fact it looks like a 100% difference between the base and reality. Told ya. Gonna be a long time before we're at 6.50 again.

US Market News

US Market News 11分前

Casey’s Announces Addition of Finance Leader Stanley J. Sutula III to its Board of DirectorsJune 8, 2026 4:00 PM
Business Wire Casey’s General Stores, Inc. (Nasdaq: CASY), the third largest convenience retailer and fifth largest pizza chain in the United States, today announced

CA Market News

CA Market News 11分前

Electric Royalties Announces Interest Conversion Under Convertible Credit FacilityJune 8, 2026 3:50 PM
ACCESS NewswireVANCOUVER, BC / ACCESS Newswire / June 8, 2026 / Electric Royalties

ollik78

ollik78 11分前

SUNE Recovery until 10 🚬 big fight

Neurizon Therapeutics

Impact Silver (QB)

Daiwa Asset Management

Jpmorgan Chase Financial...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。